Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort

about

Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort

Item

http://www.wikidata.org/entity/Q58613630

description

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Performance of prostate cancer ...... a radical prostatectomy cohort

@en

Performance of prostate cancer ...... a radical prostatectomy cohort

@nl

type

Item

label

Performance of prostate cancer ...... a radical prostatectomy cohort

@en

Performance of prostate cancer ...... a radical prostatectomy cohort

@nl

prefLabel

Performance of prostate cancer ...... a radical prostatectomy cohort

@en

Performance of prostate cancer ...... a radical prostatectomy cohort

@nl

P1476

Performance of prostate cancer ...... a radical prostatectomy cohort

@en

P2093

Aaron Hudson

http://www.w3.org/2001/XMLSchema#string

Elaine Spangler

http://www.w3.org/2001/XMLSchema#string

Karen Glanz

http://www.w3.org/2001/XMLSchema#string

Knashawn H Morales

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Multiple imputation of discrete and continuous data by fully conditional specification.

A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer.

Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy.

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.

Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer.

P2888

s12885-018-4942-0

P304

1061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4942-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charnita M Zeigler-Johnson

P577

2018-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1108011472

http://www.w3.org/2001/XMLSchema#string

P698

30390642

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

cancer research

P932

6215603

http://www.w3.org/2001/XMLSchema#string